Publication | Open Access
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
55
Citations
54
References
2020
Year
Pulmonary TuberculosisHigh-dose RifapentineMedicineTbtc Study 31/ActgTuberculosisPharmacotherapyAntimicrobial ChemotherapyPharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1